IL Ancillary Study of the Therapeutic Hypothermia After Nonshockable Cardiac Arrest Trial.

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 116 participants.

Also called NCT02711098

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 116 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02711098
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
France (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02711098. Randomized; single masking; primary purpose treatment. Start 2016-03 (registry gives no type); primary completion 2018-01-14 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
IL Ancillary Study of the Therapeutic Hypothermia After Nonshockable Cardiac Arrest Trial.
Acronym
IL-HYPERION
Intervention (Biological)
Inflammatory biomarkers dosage "Hypothermia Arm"
Intervention (Biological)
Inflammatory biomarkers dosage "Normothermia Arm"
Lead sponsor
Centre Hospitalier Departemental Vendee (class: other)

Record details

Record id
cardio:ct-nct02711098
Content hash
7f6aee275098ca7da00d815144a9ddfb9eca42aca04208d7389739cf9fb99828